Let’s take gene therapies first. In America, 17 single-dose therapies have been approved, and more than 80 are expected by 2032. So far, these treatments have been targeted at rare diseases, and many of them have the potential to cure serious or fatal illnesses such as spinal muscular atrophy and sickle cell anemia. Manufacturers charge […]